查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010036

外科医疗设备市场：2026-2032年全球市场预测（依产品、技术、材料、可携性、应用、最终用户和分销管道划分）

Surgical Devices Market by Product, Technology, Material, Portability, Application, End User, Distribution - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科医疗设备市场价值将达到 177.1 亿美元，到 2026 年将成长至 190.5 亿美元，到 2032 年将达到 303.5 亿美元，复合年增长率为 7.99%。

主要市场统计数据
基准年 2025 177.1亿美元
预计年份：2026年 190.5亿美元
预测年份 2032 303.5亿美元
复合年增长率 (%) 7.99%

为企业决策者提供权威的介绍，概述外科医疗设备市场的范围、目标和策略意义。

外科医疗设备产业正处于快速变化的临床需求、快速发展的技术以及复杂的全球供应链网路的交汇点。本报告的引言部分说明了影响各器材类别产品开发、部署管道和竞争定位的关键因素，旨在为企业主管提供参考。此外，报告还提出了核心研究问题，概述了调查方法，并为负责采购、研发优先排序和商业策略的高阶领导者阐明了实际应用案例。

科技、法规和市场的快速变化如何重塑外科手术服务的提供方式，并重新定义每个医疗设备类别的竞争优势？

近年来，变革性的变化加速了外科医疗服务和医疗设备研发的步伐。微创和机器人辅助手术技术的进步不断重塑临床路径，缩短了患者復原时间，并扩大了门诊手术的可能性。同时，能量平台和精准治疗方法日益成熟，能够实现更精准的组织相互作用，并拓展了以往仅限于急诊治疗的医疗设备的治疗范围。

评估 2025 年美国关税对外科医疗设备供应链、筹资策略和临床伙伴关係的累积影响。

美国2025年的关税政策调整为本已复杂的全球供应链引入了新的变数，改变了零件采购的经济效益、製造地的选择以及跨境库存策略。关税政策促使企业重新审视供应链设计方案，并引发了诸如重新调整采购优先事项、增加库存缓衝以及重新谈判供应商合约以抵消额外成本等短期战术性措施。这些调整也将影响资本配置决策以及企业未来在哪些地区投资生产能力。

策略性细分洞察揭示了产品、应用、技术、最终用户、材料、便携性和分销动态如何影响采用模式。

了解市场区隔对于制定产品策略和商业化计划至关重要。基于产品的市场分析涵盖内视镜、能量型医疗设备、外科植入、外科器械和手术机器人。能量型医疗设备在分析中进一步细分为电外科、射频和超音波技术，每种技术都对应不同的应用场景和监管路径。外科植入分为心血管、牙科、神经和整形外科四个子领域，每个领域都有其自身的临床证据要求和植入流程。外科器械分为入路器械、内视镜器械和通用器械，这些分类会影响消毒通讯协定、一次性使用策略和临床医生培训要求。

区域分析重点在于全球主要市场和枢纽的需求推动要素、法规环境、供应链韧性和创新热点。

区域趋势显着影响技术采纳和企业投资重点。在美洲，需求趋势显示，集中化的私人医疗网络与大规模公共医疗系统并存，后者优先考虑基于价值的采购和缩短病患住院时间。在此背景下，人们对能够减少住院时间和降低总治疗成本的微创和门诊相容设备越来越感兴趣。该地区的监管流程强调安全性和实际应用效果。因此，早期采用者通常会结合临床初步试验和健康经济学证据，说服大规模医疗机构认可其价值提案。

整合主要医疗设备製造商的产品系列、伙伴关係关係、製造地和投资趋势的竞争资讯。

企业级洞察着重分析主要企业如何将策略转化为产品组合决策、合作伙伴选择和营运执行。主要竞争对手致力于建立端到端解决方案，将医疗设备和服务、软体和培训相结合，以确保医疗效果并符合医院的品质目标。许多公司正超越单一产品竞争，转而建立平台，透过耗材、资讯服务和特定手术产品创造持续的收入来源。

为行业领导者提供切实可行的建议，以优先考虑投资和伙伴关係，从而加速安全有效地部署外科创新技术。

领导者应优先考虑如何最大限度地提高临床和商业性效益，同时增强韧性。首先，产品开发应与明确的临床路径和报销要求保持一致，确保新产品上市能够直接应对医疗服务提供者面临的挑战并符合支付方的标准。应儘早投资于上市后资料收集，将其作为临床开发的重要组成部分，以缩短从核准到医院广泛应用的时间。其次，应透过供应商多元化、确保区域製造地以及提高对二级和三级供应商的透明度，重组供应链以降低关税和地缘政治风险。这些措施将有助于降低营运风险，并确保手术的连续性。

调查方法概述了资料来源、相关人员访谈、检验程序和研究局限性，以确保严格的证据整合。

本调查方法结合了系统性的二手资料研究、与关键相关人员的对话以及结构化检验，旨在得出可操作的见解。二手资料包括监管文件、同行评审的临床文献、医疗设备附加檔和上市公司披露信息，用于建立技术、材料和医疗设备使用特征的基准。一手资料研究包括对临床医生、供应链和采购主管、监管专家以及行业策略家的访谈，以了解实际应用中的障碍、采购偏好和未满足的临床需求。

一份权威、全面的分析报告，清楚地​​概述了技术、监管和经济趋势对建构外科医疗设备产品组合的领导者的战略意义。

总之，本报告总结了高阶主管在技术进步和供应链日益复杂的环境下需要应对的关键要点。微创手术和能量平台的技术创新不断改变临床工作流程，而监管和采购压力凸显了对可验证的成果和成本效益的迫切需求。不断变化的供应链和贸易政策迫使各组织重新评估筹资策略，并投资于生产的柔软性和透明度。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科医疗设备市场：依产品划分

  • 内视镜
  • 基于能量的设备
    • 用于电外科手术
    • 高频
    • 超音波
  • 外科植入
    • 心血管系统
    • 牙科
    • 神经
    • 整形外科
  • 手术器械
    • 存取装置
    • 内视镜
    • 整体的
  • 手术机器人

第九章 外科医疗设备市场：依技术划分

  • 高强度聚焦超音波
  • 雷射手术
  • 微创
    • 内视镜
    • 腹腔镜手术
    • 机器人支援
  • 开放性手术

第十章 外科医疗设备市场：依材料分类

  • 复合材料
  • 聚合物
  • 不銹钢
  • 钛

第十一章：外科医疗设备市场－便携性

  • 携带式的
  • 固定式

第十二章 外科医疗设备市场：依应用领域划分

  • 循环系统
  • 整体的
  • 妇科
  • 神经外科
  • 整形外科
  • 泌尿系统

第十三章 外科医疗设备市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院
  • 专业外科中心

第十四章：依分销管道分類的外科医疗设备市场

  • 离线
  • 在线的

第十五章 外科医疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 外科医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 外科医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国外科医疗设备市场

第十九章：中国外科医疗设备市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acumed LLC
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • CONMED Corporation
  • Corin Group plc
  • DePuy Synthes, Inc.
  • Enovis Corporation
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Paragon 28, Inc.
  • SeaSpine Holdings Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-434CCDA04F06

The Surgical Devices Market was valued at USD 17.71 billion in 2025 and is projected to grow to USD 19.05 billion in 2026, with a CAGR of 7.99%, reaching USD 30.35 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.71 billion
Estimated Year [2026] USD 19.05 billion
Forecast Year [2032] USD 30.35 billion
CAGR (%) 7.99%

An authoritative introduction outlining the scope, objectives, and strategic relevance of the surgical devices landscape for executive decision-makers

The surgical devices domain sits at the intersection of fast-moving clinical need, rapid technological advancement, and complex global supply networks. This report's introduction orients executive readers to the principal forces shaping product development, adoption pathways, and competitive positioning across device categories. It frames the core research questions, outlines the methodological approach, and clarifies the practical use cases for senior leaders responsible for procurement, R&D prioritization, and commercial strategy.

Beginning with clinical imperatives, the introduction connects evolving standards of care and demographic pressure points to the innovation priorities of device manufacturers and health systems. It then transitions to the regulatory and reimbursement context, emphasizing how policy shifts and payer expectations alter commercialization pathways. Finally, the introduction highlights the interplay between manufacturing footprint decisions and logistical resilience, establishing a baseline for later sections that explore segmentation, regional dynamics, and company-level strategies. This orientation prepares readers to interpret the evidence with an operational mindset and to apply the insights to near-term planning cycles.

How rapid technological, regulatory, and market forces are reshaping surgical care delivery and redefining competitive advantage across device categories

Over the last several years, transformative shifts have accelerated the pace at which surgical care is delivered and devices are developed. Advances in minimally invasive and robotic-assisted techniques continue to redefine clinical pathways by reducing patient recovery time and expanding outpatient procedure feasibility. At the same time, energy-based platforms and precision modalities have matured, enabling more targeted tissue interaction and broadening the therapeutic footprint of devices previously confined to acute settings.

Concurrently, supply chain resilience and manufacturing agility have moved to the forefront of strategic planning. Manufacturers now prioritize flexible production lines and dual-source procurement to mitigate disruptions. Regulatory and compliance landscapes have also adapted, with regulators increasingly emphasizing real-world evidence and post-market surveillance as part of approval and lifecycle management processes. These regulatory dynamics create both friction and opportunity: companies that align clinical evidence generation with regulatory expectations can shorten commercialization timelines and reduce reimbursement friction.

Finally, the competitive architecture has shifted toward ecosystems rather than single-product plays. Partnerships across medtech, software, and services create bundled offerings that deliver clinical and operational value beyond product specifications. As payers and providers demand demonstrable outcomes and cost-effectiveness, companies that invest in integrated care solutions and data-driven value propositions will secure differentiated positions in procurement conversations.

Assessing the cumulative impact of United States tariffs in 2025 on supply chains, procurement strategies and clinical partnerships in surgical devices

United States tariff policy changes in 2025 introduced a new variable into an already complex global supply environment, altering the economics of component sourcing, manufacturing location decisions, and cross-border inventory strategies. Tariffs increased the impetus for companies to examine supply chain design choices, prompting near-term tactical responses such as reprioritizing procurement, raising inventory buffers, and renegotiating supplier contracts to offset incremental costs. Over time, these adjustments influence capital allocation decisions and where companies choose to invest in manufacturing capacity.

In addition to direct cost impacts, tariff shifts affected strategic partnerships and clinical collaborations. Providers and device manufacturers reassessed vendor relationships to ensure continuity of critical consumables and to reduce exposure to tariff volatility. This led to greater interest in domestically sourced components or alternate regional suppliers. Investment in supply chain visibility and analytics accelerated, as leaders sought to quantify exposure and model scenario impacts on product availability for elective and urgent procedures.

Finally, the tariff environment contributed to a renewed focus on design for manufacturability and material choices that reduce dependence on tariff-sensitive inputs. Organizations moved to validate alternative materials and to adapt product architectures where clinically feasible. These cumulative responses demonstrate how trade policy can cascade through procurement practices, clinical supply reliability, and long-term innovation strategies, prompting a rebalancing of risk and resilience considerations across the device lifecycle.

Strategic segmentation insights revealing product, application, technology, end user, material, portability and distribution dynamics shaping adoption patterns

Understanding segmentation is essential for shaping product strategy and commercialization plans. Based on Product, market analysis includes Endoscopes, Energy-Based Devices, Surgical Implants, Surgical Instruments, and Surgical Robots. Within Energy-Based Devices, the analysis further distinguishes Electrosurgical, Radio Frequency, and Ultrasound technologies, reflecting distinct clinical use cases and regulatory pathways. Surgical Implants are categorized into Cardiovascular, Dental, Neurological, and Orthopedic subsegments, each governed by unique clinical evidence requirements and implantation workflows. Surgical Instruments are differentiated across Access Devices, Endoscopic, and General instrument groups, which influence sterilization protocols, disposable strategies, and clinician training demands.

When viewed Based on Application, the report tracks device intersection with Cardiovascular, General, Gynecology, Neurological, Orthopedic, and Urology indications, connecting clinical outcomes imperatives to adoption timing and purchasing behavior. Based on Technology, technologies of interest include High-Intensity Focused Ultrasound, Laser Surgery, Minimally Invasive, and Open Surgery. The Minimally Invasive category is further subdivided into Endoscopic, Laparoscopic, and Robotic Assisted techniques, an important distinction because each pathway entails different capital equipment, procedural staffing, and training investments for provider organizations.

From the end-user perspective, Based on End User, the study evaluates demand dynamics across Ambulatory Surgical Centers, Clinics, Hospitals, and Specialty Surgical Centers, recognizing that care setting influences purchasing cycles, sterilization infrastructure needs, and reimbursement contexts. Materials matter as well; Based on Material, devices and implants are examined across Composite, Polymers, Stainless Steel, and Titanium selections, which affect device longevity, biocompatibility considerations, and cost structure. Finally, Based on Portability, the market differentiates Portable versus Stationary solutions, and Based on Distribution, the analysis considers Direct Sales, Distributors, and Online Sales channels. This layered segmentation provides a nuanced view that links product architecture to clinical workflows, procurement behavior, and channel economics.

Regional intelligence highlighting demand drivers, regulatory environments, supply chain resilience, and innovation hotspots across key global markets and hubs

Regional dynamics materially shape how technologies diffuse and how companies prioritize investments. In the Americas, demand patterns reflect a concentrated private provider network alongside large public health systems that emphasize value-based procurement and shorter patient stays. This environment drives interest in minimally invasive and ambulatory-capable devices that reduce length of stay and total episode cost. Regulatory pathways in the region emphasize both safety and real-world performance; as a result, early adopters often couple clinical pilots with health-economic evidence to convince larger providers of the value proposition.

In Europe, Middle East & Africa, heterogeneous regulatory regimes, procurement frameworks, and healthcare financing models create both complexity and opportunity. Fragmented reimbursement landscapes mean that localized clinical and economic value arguments prove necessary. Supply chain resilience remains a priority across the region, and manufacturers frequently adopt region-specific manufacturing or distribution strategies to maintain competitive pricing while meeting regulatory compliance.

Asia-Pacific markets are notable for rapid technology uptake in select urban centers, aggressive investment in surgical robotics and minimally invasive platforms, and growing domestic manufacturing capabilities. The pace of adoption varies with local clinician training capacity and funding models, but the region collectively represents fertile ground for scalable manufacturing strategies and partnerships that target both high-volume urban centers and expanding secondary markets. Across regions, leaders must tailor go-to-market approaches to local procurement drivers, regulatory expectations, and clinical workforce realities while maintaining a coherent global product and evidence strategy.

Competitive intelligence synthesizing product portfolios, partnerships, manufacturing footprints and investment trends among leading device manufacturers

Company-level insights focus on how leading organizations translate strategy into portfolio decisions, partner selection, and operational execution. Top competitors concentrate on building end-to-end solutions that combine devices with services, software, and training to lock in clinical outcomes and align with hospital quality goals. Many firms have moved beyond single-product competition to create platforms that enable recurring revenue streams through consumables, data services, and procedure-specific offerings.

Strategic alliances and M&A activity continue to reconfigure capability maps, with mid-sized firms often acting as innovation engines that larger players acquire to accelerate entry into adjacent technology areas. Manufacturing footprint optimization and investments in automation have become important differentiators for players seeking to reduce per-unit cost volatility and to maintain supply assurance for high-use consumables. Meanwhile, companies that demonstrate robust post-market surveillance and that invest in real-world evidence generation find improved receptivity among payers and health systems.

Finally, commercial models are evolving. Direct sales remain key in high-touch, capital-intensive segments, while distributors and digital channels expand access for lower-cost or consumable-driven product lines. The ability of a company to align its sales model to the customer setting-ambulatory center versus tertiary hospital, for example-affects adoption speed and long-term account penetration. These trends underscore the need for an integrated approach to portfolio management, operational resilience, and customer engagement.

Actionable recommendations for industry leaders to prioritize investments and partnerships that accelerate safe and efficient surgical innovation adoption

Leaders should prioritize actions that enhance resilience while unlocking clinical and commercial upside. First, align product development with clearly defined clinical pathways and reimbursement evidence needs so that new launches directly address provider pain points and payer thresholds. Invest early in post-market data collection as an integral part of clinical development to shorten the time from approval to widespread hospital adoption. Second, re-evaluate supply chain architectures to reduce tariff and geopolitical exposure by diversifying suppliers, creating regional manufacturing options, and increasing visibility into tier-two and tier-three sourcing. These steps will reduce operational risk and protect procedure continuity.

Third, cultivate partnerships across technology, software, and services to build bundled solutions that deliver measurable outcomes and operational efficiencies. Such collaborations not only improve competitiveness but also create higher switching costs for customers. Fourth, tailor commercialization strategies to care settings by deploying direct sales in capital-intensive hospital segments while leveraging distributors and digital channels for ambulatory and consumable-driven markets. Finally, embed adaptive pricing and contracting approaches that reflect value-based procurement trends, enabling more flexible engagement with payers and large provider networks.

Taken together, these recommendations balance risk mitigation with growth orientation, providing leaders with a pragmatic roadmap for prioritizing investments, forging strategic alliances, and operationalizing evidence generation to support sustainable clinical adoption.

Research methodology outlining data sources, stakeholder interviews, validation procedures and study limitations to ensure rigorous evidence synthesis

The research methodology combines systematic secondary research with primary stakeholder engagement and structured validation to produce actionable findings. Secondary inputs included regulatory filings, peer-reviewed clinical literature, device labeling documents, and public company filings to establish baseline technology, material, and device usage characteristics. Primary research included interviews with clinicians, supply chain and procurement executives, regulatory specialists, and industry strategists to capture real-world adoption barriers, procurement preferences, and unmet clinical needs.

Analytical frameworks applied in the study include value chain mapping, scenario-based supply chain stress testing, and comparative product capability assessment. Where appropriate, evidence triangulation validated claims about clinical performance, manufacturing implications, and commercial traction. The methodology also documents limitations, including variability across local reimbursement pathways and differences in clinician training programs that affect adoption timing. To address these constraints, the study reports confidence bounds around qualitative judgments and specifies instances where local validation is recommended.

Overall, this structured approach ensures the findings are grounded in multiple data streams and stakeholder perspectives. It also creates traceability between observations, underlying evidence, and the conclusions presented, supporting both internal strategy discussions and external stakeholder briefings.

Conclusive synthesis articulating the strategic implications of technological, regulatory and economic trends for leaders shaping surgical device portfolios

The conclusion synthesizes the report's principal takeaways for executives seeking to navigate an environment of technological advance and supply chain complexity. Technological innovation in minimally invasive procedures and energy-based platforms continues to reshape clinical workflows, while regulatory and procurement pressures emphasize the need for demonstrable outcomes and cost-effectiveness. Supply chain and trade policy shifts compel organizations to reassess sourcing strategies and to invest in manufacturing flexibility and visibility.

Taken together, these dynamics favor companies that can combine clinical differentiation with operational resilience and who can present compelling, evidence-based value propositions to payers and providers. Strategic partnerships, targeted capital allocation, and adaptable commercialization models will determine which organizations capture sustained adoption across care settings. Leaders should therefore apply the report's segmentation and regional insights to prioritize initiatives that align with both near-term operational needs and long-term portfolio ambitions.

In sum, the surgical devices landscape rewards integrated thinking: those that coordinate product design, supply chain strategy, and clinical evidence generation will be best positioned to convert innovation into lasting clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Devices Market, by Product

  • 8.1. Endoscopes
  • 8.2. Energy-Based Devices
    • 8.2.1. Electrosurgical
    • 8.2.2. Radio Frequency
    • 8.2.3. Ultrasound
  • 8.3. Surgical Implants
    • 8.3.1. Cardiovascular
    • 8.3.2. Dental
    • 8.3.3. Neurological
    • 8.3.4. Orthopedic
  • 8.4. Surgical Instruments
    • 8.4.1. Access Devices
    • 8.4.2. Endoscopic
    • 8.4.3. General
  • 8.5. Surgical Robots

9. Surgical Devices Market, by Technology

  • 9.1. High-Intensity Focused Ultrasound
  • 9.2. Laser Surgery
  • 9.3. Minimally Invasive
    • 9.3.1. Endoscopic
    • 9.3.2. Laparoscopic
    • 9.3.3. Robotic Assisted
  • 9.4. Open Surgery

10. Surgical Devices Market, by Material

  • 10.1. Composite
  • 10.2. Polymers
  • 10.3. Stainless Steel
  • 10.4. Titanium

11. Surgical Devices Market, by Portability

  • 11.1. Portable
  • 11.2. Stationary

12. Surgical Devices Market, by Application

  • 12.1. Cardiovascular
  • 12.2. General
  • 12.3. Gynecology
  • 12.4. Neurological
  • 12.5. Orthopedic
  • 12.6. Urology

13. Surgical Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals
  • 13.4. Specialty Surgical Centers

14. Surgical Devices Market, by Distribution

  • 14.1. Offline
  • 14.2. Online

15. Surgical Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Surgical Devices Market

19. China Surgical Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Acumed LLC
  • 20.6. Arthrex, Inc.
  • 20.7. B. Braun Melsungen AG
  • 20.8. CONMED Corporation
  • 20.9. Corin Group plc
  • 20.10. DePuy Synthes, Inc.
  • 20.11. Enovis Corporation
  • 20.12. Exactech, Inc.
  • 20.13. Globus Medical, Inc.
  • 20.14. Integra LifeSciences Holdings Corporation
  • 20.15. Medtronic plc
  • 20.16. MicroPort Scientific Corporation
  • 20.17. NuVasive, Inc.
  • 20.18. Orthofix Medical Inc.
  • 20.19. Paragon 28, Inc.
  • 20.20. SeaSpine Holdings Corporation
  • 20.21. Smith & Nephew plc
  • 20.22. Stryker Corporation
  • 20.23. Zimmer Biomet Holdings, Inc.
  • 20.24. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL DEVICES MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ACCESS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LASER SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL DEVICES MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL DEVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL DEVICES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL DEVICES MARKET SIZE, BY SPECIALTY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. GCC SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 245. GCC SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. GCC SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. GCC SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 250. GCC SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. GCC SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 252. GCC SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. GCC SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. GCC SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 279. G7 SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. G7 SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 281. G7 SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 282. G7 SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 283. G7 SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 284. G7 SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. G7 SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 287. G7 SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 288. G7 SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. G7 SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. G7 SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 291. NATO SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. NATO SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 293. NATO SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. NATO SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 295. NATO SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 296. NATO SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 297. NATO SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 299. NATO SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 300. NATO SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. NATO SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. NATO SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA SURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA SURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA SURGICAL DEVICES MARKET SIZE, BY ENERGY-BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA SURGICAL DEVICES MARKET SIZE, BY SURGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA SURGICAL DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA SURGICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA SURGICAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA SURGICAL DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA SURGICAL DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA SURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA SURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA SURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)